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Résumé en
anglais
OBJECTIVE: To assess incidence and prognostic significance of bacterial infections
(BIs) occurring in compensated viral cirrhosis.
DESIGN: This prospective study involved 35 French centres. Inclusion criteria were
biopsy-proven HCV or HBV cirrhosis, Child-Pugh A and no previous hepatic
complications. Cumulative incidence (CumI) of events was estimated in a competing
risks framework.
RESULTS: 1672 patients were enrolled (HCV 1323, HBV 318, HCV-HBV 31). During
a median follow-up of 43 months, 234 BIs occurred in 171 patients (5 year CumI:
12.9%), among whom 14.6% had septic shock. Main localisations included the
urinary tract (27.4%), lung (25.2%) and peritoneum (10.7%) (other, 86 (36.7%)).
Most BIs occurred as a first event prior to liver decompensation (n=140, 81.8%) and
were community-acquired (CA, 84.2%). The risk of BI was higher in patients with
HCV than in patients with HBV (5 year CumI: 15.2% vs 5.5%, p=0.0008). Digestive
localisation, concomitant interferon-based treatment, isolation of resistant bacteria
and non-CA BIs were associated with lowest probability of resolution. The
occurrence of a first BI impaired survival in patients infected with HCV (5 year
survival: 60.2% vs 90.4%, p<0.001) and patients infected with HBV (5 year survival:
69.2% vs 97.6%, p<0.001). BIs represented the third cause of death (14.1%) after
liver failure and liver cancer. BI risk factors comprised older age, lower albumin,
proton pump inhibitor intake and absence of virological eradication/control.
CONCLUSION: BI mostly occurs as a first complication and represents a turning
point in the course of compensated viral cirrhosis. Its occurrence impacts long-term


















































































Publié sur Okina (http://okina.univ-angers.fr)
